Karen Appold

Managed Healthcare Executive asked some chief executives what their biggest challenge has been, and how they have worked to overcome it. Here’s what they had to say.

The first step in helping consumers navigate the cost of care is to provide them with a basic understanding of what healthcare services actually cost.

Managed Healthcare Executive has identified 10 emerging industry leaders, working in the areas of pharmacy, health plans, health systems, and technology.

The disease management and insurer initiatives changing the diabetes landscape.

While the Democratic House and Democratic presidential candidates tout Medicare for All, opposing forces are also at work.

No longer a pipe-dream of fringe policy makers, Medicare for All is gaining serious support-and criticism. Here’s what you need to know about the current conversation.

How are employers coping with rising healthcare costs?

Here’s five things to take away from Anthem’s launch of PBM IngenioRx.

A southern California health system asked its in-hospital physician groups to contract with its insurance carriers. Here’s what happened.

Health plans have limited budgets for technology innovations. Here are eight questions to ask to help you determine what new technologies will offer the most value.

Experts discuss what these trends entail, what’s giving them momentum, and how executives can get on board.

HHS releases voluntary Cybersecurity Practices guidance. Industry analysts drill down deeper.

Here’s what healthcare organizations will face in the year ahead, and expert advice on how to deal.

Autoimmune diseases often impact many organ systems and are complex, requiring a number of specialists to manage them. Here’s a snapshot of an interesting new model that addresses care challenges of these diseases.

Most autoimmune diseases don’t have cures. Here are the top ways providers can manage and control them.

Slightly less than in 2018, approximately 8.5 million people signed up to obtain health insurance for 2019 through the ACA marketplace exchange. Here are five things that may or may not have affected these numbers.

Here’s a look at three innovative drugs used to treat autoimmune conditions that made the news this year.

Because of the inflammatory nature of psoriasis, biologics are good drug candidates, but could affect cost and reimbursement.

In an effort to lower prescription drug prices, CMS unveiled proposed polices for 2020 to strengthen and modernize the Medicare Part C and D programs. Here’s a closer look at what CMS’ provisions entail and how they help accomplish the Administration’s four strategies.

Medicare Advantage enrollees can expect new benefits with the start of 2019. Here's what healthcare executives should know.

Here’s how experts predict healthcare will unfold in 2019.

There has been an increase in the number of people with autoimmune diseases. Here’s what you should know about them.

Autoimmune patients suffer a variety of comorbidities and often require extra care-here’s how the costs of that care can be reduced.

Here are five things managed care executives should know about the proposed plan.

Four things you need to know about the Trump Administration’s proposed regs.

There has been an increase in the number of people with autoimmune diseases. Here’s what you should know about them.

A chief executive officer must have a more diverse team to address the rising complexity and velocity of healthcare. Here are four positions that managed care organizations may want to seriously consider.

Experts predict what oncology care will look like a decade from now.

Managing psoriasis can be difficult for a variety of reasons. Here’s a look at the top six challenges that experts identified.

Individuals with immune-mediated diseases, such as psoriasis, are at higher risk for having other immune-mediated diseases. Here’s how psoriasis can lead to other conditions, and the associated costs.